Tr1 and naturally occurring regulatory T cells induce IgG4 in B cells through GITR/GITR‐L interaction, IL‐10 and TGF‐β

Regulatory T cells exert their function through the modulation of both T and B cell responses. Our previous studies demonstrated that IL‐10‐producing Treg (Tr1) can induce B cells to secrete IgG4 in a cell‐contact‐dependent manner. The benefit of such non‐inflammatory B‐cell responses is apparent in the hyporesponsive state of patients with helminth infections such as Onchocerciasis. Here, we investigated the mechanisms involved to induce IgG4, within B:Tr‐cell co‐cultures, using IL‐10‐producing tetanus‐toxoid‐specific regulatory T cell lines and clones (Tr‐TCC) from human PBMC. During the generation process, we found that increasing Foxp3 levels in regulatory T cell lines correlated with their ability to induce IgG4 in B cells. Using Tr‐TCC, we found that blocking glucocorticoid‐induced tumour necrosis factor receptor‐related protein (GITR) molecules selectively prevented IgG4 production as did neutralizing Ab to glucocorticoid‐induced tumour necrosis factor receptor‐related protein ligand (GITR‐L), IL‐10 and TGF‐β. Furthermore, the prevention of IgG4 induction by anti‐GITR Ab was reversed by excess rIL‐10 but not rTGF‐β. In contrast, anti‐ICOS and anti‐CTLA‐4 Abs had no effect. When compared with Tr‐TCC, freshly isolated CD4+CD25+ T cells, but not effector T cell populations, induced low levels of IgG4, which were also blocked by anti‐GITR and anti‐GITR‐L Ab. Thus, the mechanism of IgG4 induction by regulatory cells involves GITR–GITR‐L interactions, IL‐10 and TGF‐β.

[1]  A. E. Sousa,et al.  Expansion of circulating Foxp3+CD25bright CD4+ T cells during specific venom immunotherapy , 2007, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[2]  P. Zhou,et al.  Pivotal Roles of CD4+ Effector T cells in Mediating Agonistic Anti-GITR mAb-Induced-Immune Activation and Tumor Immunity in CT26 Tumors , 2007, The Journal of Immunology.

[3]  U. Grohmann,et al.  IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-κB activation , 2007, Nature Reviews Immunology.

[4]  B. Baban,et al.  Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. , 2007, The Journal of clinical investigation.

[5]  P. Reichardt,et al.  Naive B cells generate regulatory T cells in the presence of a mature immunologic synapse. , 2007, Blood.

[6]  T. Nicolai,et al.  Quantitative and functional impairment of pulmonary CD4+CD25hi regulatory T cells in pediatric asthma. , 2007, The Journal of allergy and clinical immunology.

[7]  S. Cuzzocrea,et al.  GITR/GITRL: More than an effector T cell co‐stimulatory system , 2007, European journal of immunology.

[8]  L. Boon,et al.  Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy , 2007, Nature Medicine.

[9]  Katharina Fleischhauer,et al.  Interleukin‐10‐secreting type 1 regulatory T cells in rodents and humans , 2006, Immunological reviews.

[10]  E. Shevach,et al.  The GITR–GITRL interaction: co-stimulation or contrasuppression of regulatory activity? , 2006, Nature Reviews Immunology.

[11]  S. Cobbold,et al.  The hidden truth about gene expression in Tregs: Is it what you don't see that counts? , 2006, European journal of immunology.

[12]  Sabah Khalid,et al.  Persistent antigenic stimulation alters the transcription program in T cells, resulting in antigen‐specific tolerance , 2006, European journal of immunology.

[13]  M. Battaglia,et al.  Tr1 cells: from discovery to their clinical application. , 2006, Seminars in immunology.

[14]  P. Puccetti,et al.  Immunity and Tolerance to Aspergillus Involve Functionally Distinct Regulatory T Cells and Tryptophan Catabolism1 , 2006, The Journal of Immunology.

[15]  Cezmi A Akdis,et al.  T regulatory cells in allergy: novel concepts in the pathogenesis, prevention, and treatment of allergic diseases. , 2005, The Journal of allergy and clinical immunology.

[16]  T. Nomura,et al.  Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells , 2005, The Journal of experimental medicine.

[17]  B. Rouse,et al.  In Vivo Kinetics of GITR and GITR Ligand Expression and Their Functional Significance in Regulating Viral Immunopathology , 2005, Journal of Virology.

[18]  G. Lindahl,et al.  Induction of a Regulatory Phenotype in Human CD4+ T Cells by Streptococcal M Protein1 , 2005, The Journal of Immunology.

[19]  Helen Faulkner,et al.  Allergen-specific IgE and IgG4 are markers of resistance and susceptibility in a human intestinal nematode infection. , 2005, Microbes and infection.

[20]  A. Hoerauf,et al.  T Regulatory-1 Cells Induce IgG4 Production by B Cells: Role of IL-101 , 2005, The Journal of Immunology.

[21]  C. Riccardi,et al.  GITR: a multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily , 2005, European journal of immunology.

[22]  M. Roncarolo,et al.  Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells. , 2005, Blood.

[23]  Ethan M. Shevach,et al.  Engagement of Glucocorticoid-Induced TNFR Family-Related Receptor on Effector T Cells by its Ligand Mediates Resistance to Suppression by CD4+CD25+ T Cells , 2004, The Journal of Immunology.

[24]  D. Munn,et al.  Ido expression by dendritic cells: tolerance and tryptophan catabolism , 2004, Nature Reviews Immunology.

[25]  C. Akdis,et al.  T Regulatory Cells in Allergy and Health: A Question of Allergen Specificity and Balance , 2004, International Archives of Allergy and Immunology.

[26]  W. Faubion,et al.  Cutting Edge: The Natural Ligand for Glucocorticoid-Induced TNF Receptor-Related Protein Abrogates Regulatory T Cell Suppression 1 , 2004, The Journal of Immunology.

[27]  S. Miller,et al.  Cutting Edge: Ligation of the Glucocorticoid-Induced TNF Receptor Enhances Autoreactive CD4+ T Cell Activation and Experimental Autoimmune Encephalomyelitis1 , 2004, The Journal of Immunology.

[28]  B. Kwon,et al.  Cloning and characterization of GITR ligand , 2003, Genes and Immunity.

[29]  H. Waldmann,et al.  Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A. Rudensky,et al.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.

[31]  Manuela Battaglia,et al.  Human CD25+CD4+ T Suppressor Cell Clones Produce Transforming Growth Factor β, but not Interleukin 10, and Are Distinct from Type 1 T Regulatory Cells , 2002, The Journal of experimental medicine.

[32]  U. Grohmann,et al.  CTLA-4–Ig regulates tryptophan catabolism in vivo , 2002, Nature Immunology.

[33]  A. Hoerauf,et al.  Antigen-specific T regulatory-1 cells are associated with immunosuppression in a chronic helminth infection (onchocerciasis). , 2002, Microbes and infection.

[34]  A. Enk,et al.  Infectious Tolerance , 2002, The Journal of experimental medicine.

[35]  A. Nagler,et al.  Dexamethasone inhibits maturation, cytokine production and FcεRI expression of human cord blood‐derived mast cells , 2002 .

[36]  J. Shimizu,et al.  Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance , 2002, Nature Immunology.

[37]  A. Enk,et al.  Induction of Interleukin 10–Producing, Nonproliferating Cd4+ T Cells with Regulatory Properties by Repetitive Stimulation with Allogeneic Immature Human Dendritic Cells , 2000, The Journal of experimental medicine.

[38]  A. Hoerauf,et al.  Antigen-specific cellular hyporesponsiveness in a chronic human helminth infection is mediated by Th3/Tr1-type cytokines IL-10 and transforming growth factor-β but not by a Th1 to Th2 shift , 2000 .

[39]  R. Van Ree,et al.  Normal human immunoglobulin G4 is bispecific: it has two different antigen‐combining sites , 1999, Immunology.

[40]  R. de Boer,et al.  In vitro production of IgG4 by peripheral blood mononuclear cells (PBMC): the contribution of committed B cells , 1998, Clinical and experimental immunology.

[41]  Hervé Groux,et al.  A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis , 1997, Nature.

[42]  C. Riccardi,et al.  A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[43]  D. Gray,et al.  CD40 ligand-transduced co-stimulation of T cells in the development of helper function , 1995, Nature.

[44]  A. Dessein,et al.  Strong serum inhibition of specific IgE correlated to competing IgG4, revealed by a new methodology in subjects from a S. mansoni endemic area , 1992, European journal of immunology.

[45]  R. Aalberse,et al.  Inhibition of complement activation by IgG4 antibodies. , 1986, Clinical and experimental immunology.

[46]  M. Radwan,et al.  The characterization and role of regulatory T cells in immune reactions. , 2008, Frontiers in bioscience : a journal and virtual library.

[47]  E. Pearce,et al.  Regulatory T Cell Responses Develop in Parallel to Th Responses and Control the Magnitude and Phenotype of the Th Effector Population , 2006 .

[48]  M. Roncarolo,et al.  Differentiation of Tr 1 cells by immature dendritic cells requires IL-10 but not CD 25 CD 4 Tr cells , 2005 .

[49]  A. Rudensky,et al.  Foxp 3 programs the development and function of CD 4 + CD 25 + regulatory T cells , 2003 .

[50]  A. Hoerauf,et al.  Antigen-specific cellular hyporesponsiveness in a chronic human helminth infection is mediated by T(h)3/T(r)1-type cytokines IL-10 and transforming growth factor-beta but not by a T(h)1 to T(h)2 shift. , 2000, International immunology.